Preprint · CC-BY
via OpenAlex
Betalain- and betacyanin-rich supplements’ impacts on the PBMC SIRT1 and LOX1 genes expression and Sirtuin-1 protein levels in coronary artery disease patients: A pilot crossover clinical trial
Parisa Rahimi, Seyed Alireza Mesbah‐Namin, Alireza Ostadrahimi, Ahmad Separham, Mohammad Asghari Jafarabadi
Journal of Functional Foods · 2019 · ▲ 41 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jff.2019.06.003
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Rahimi, P., Mesbah‐Namin, S.A., Ostadrahimi, A., Separham, A., & Jafarabadi, M.A. (2019). Betalain- and betacyanin-rich supplements’ impacts on the PBMC SIRT1 and LOX1 genes expression and Sirtuin-1 protein levels in coronary artery disease patients: A pilot crossover clinical trial. <em>Journal of Functional Foods</em>. https://doi.org/10.1016/j.jff.2019.06.003
Vancouver
Rahimi P, Mesbah‐Namin SA, Ostadrahimi A, Separham A, Jafarabadi MA. Betalain- and betacyanin-rich supplements’ impacts on the PBMC SIRT1 and LOX1 genes expression and Sirtuin-1 protein levels in coronary artery disease patients: A pilot crossover clinical trial. Journal of Functional Foods. 2019. doi:10.1016/j.jff.2019.06.003.
BibTeX
@unpublished{parisa2019Betala,
title = {Betalain- and betacyanin-rich supplements’ impacts on the PBMC SIRT1 and LOX1 genes expression and Sirtuin-1 protein levels in coronary artery disease patients: A pilot crossover clinical trial},
author = {Parisa Rahimi and Seyed Alireza Mesbah‐Namin and Alireza Ostadrahimi and Ahmad Separham and Mohammad Asghari Jafarabadi},
journal = {Journal of Functional Foods},
year = {2019},
doi = {10.1016/j.jff.2019.06.003},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Heike A. Bischoff-Ferrari, Prof. Dr. med., DrPH 2026
Open access · US-GOV
PrecisionAge Pilot Study
Neurological Sciences 2019
Citation only
Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis
Parkinsonism & Related Disorders 2020
Preprint · OA
Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease
Journal of Neural Transmission 2006
Preprint · CC-BY
The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy
Acta Pharmacologica Sinica 2022
Open access · OA
Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?
Zealand University Hospital 2019
Open access · US-GOV